Severity-dependent and sex-biased dysregulation of A-to-I RNA editing in COVID-19 reveals CTSS as a key regulatory target.
5 affiliations
- 1Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Department of Respiratory and Critical Care Medicine, Affiliated Wuxi Fifth Hospital of Jiangnan University, Jiangnan University, Wuxi, Jiangsu, China.
- 2Joint Primate Research Center for Chronic Diseases, Institute of Zoology of Guangdong Academy of Sciences, Jiangnan University, Wuxi, Jiangsu, China.
- 3MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
- 4Department of Respiratory and Critical Care Medicine, Affiliated Wuxi Fifth Hospital of Jiangnan University, Wuxi, Jiangsu, China.
- 5School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Abstract
SARS-CoV-2 infection causes diverse clinical outcomes, with men facing higher risks of severe disease. Adenosine-to-inosine (A-to-I) RNA editing mediated by ADAR enzymes governs innate antiviral immunity, yet its contribution to COVID-19 severity and sex-biased disease remains unclear. We performed epitranscriptomic profiling on 126 blood samples from non-COVID controls and COVID-19 patients spanning different disease severities. We detected 1,466 differentially RNA-edited sites in 514 genes linked to clinical outcomes. Although ADAR expression increased in COVID-19 patients overall, it was strongly reduced in ICU patients compared with non-ICU patients, and this shift was far more prominent in males. This severity-associated and sex-biased ADAR/ADARB1 downregulation coincided with decreased global RNA editing and perturbed expression of immune-related edited transcripts. Cathepsin S (CTSS) was identified as a central regulatory node: elevated A-to-I editing within its 3' UTR in ICU patients stabilizes CTSS mRNA. Without stratifying by disease severity, ADAR expression and global editing showed no significant sex differences; the large sex divergence only appeared among ICU patients. This indicates severity-dependent, not infection-innate, disruption of A-to-I editing, disproportionately amplified in critically ill males. CTSS 3'UTR editing may serve as a biomarker for patient stratification, revealing a mechanistic connection between epitranscriptomic changes and male-biased severe COVID-19.
Related
- Physiological Reference Mapping Reveals Context-Dependent Dysregulation of Regenerative Programs in Duchenne Muscular Dystrophy.
- Precision Editing of Cis-Regulatory Elements Drives Crops Quantitative Traits Genetic Improvement: From Functional Dissection to Intelligent Design.
- Editing the Embryonic Brain: How In Utero Electroporation Reveals the Secrets of Cortical Development
- Single-nucleus multiome profiling reveals osteocyte-centered remodeling of human subchondral bone across osteoarthritis severity
- Base editing reveals an essential role for NANOG in human embryogenesis
BibTeX
@article{wang2026severitydependent,
title = {{Severity-dependent and sex-biased dysregulation of A-to-I RNA editing in COVID-19 reveals CTSS as a key regulatory target.}},
author = {Jing-Yuan Wang and Ya-Di Zhao and Li-Ping Wang and Yu-Qing Ren and Jia-Nuo Li and Teng Wang and Hua-Kang Zhang and Feng Zhu and Jian-Huan Chen and Yun-Yun Jin},
journal = {RNA biology},
year = {2026},
month = oct,
doi = {10.1080/15476286.2026.2736869},
url = {https://europepmc.org/article/MED/42872762},
note = {CC BY},
}
RIS
TY - JOUR
TI - Severity-dependent and sex-biased dysregulation of A-to-I RNA editing in COVID-19 reveals CTSS as a key regulatory target.
AU - Jing-Yuan Wang
AU - Ya-Di Zhao
AU - Li-Ping Wang
AU - Yu-Qing Ren
AU - Jia-Nuo Li
AU - Teng Wang
AU - Hua-Kang Zhang
AU - Feng Zhu
AU - Jian-Huan Chen
AU - Yun-Yun Jin
PY - 2026
DA - 2026/10/14
JO - RNA biology
DO - 10.1080/15476286.2026.2736869
UR - https://europepmc.org/article/MED/42872762
AB - SARS-CoV-2 infection causes diverse clinical outcomes, with men facing higher risks of severe disease. Adenosine-to-inosine (A-to-I) RNA editing mediated by ADAR enzymes governs innate antiviral immunity, yet its contribution to COVID-19 severity and sex-biased disease remains unclear. We performed epitranscriptomic profiling on 126 blood samples from non-COVID controls and COVID-19 patients spanning different disease severities. We detected 1,466 differentially RNA-edited sites in 514 genes linked to clinical outcomes. Although ADAR expression increased in COVID-19 patients overall, it was strongly reduced in ICU patients compared with non-ICU patients, and this shift was far more prominent in males. This severity-associated and sex-biased ADAR/ADARB1 downregulation coincided with decreased global RNA editing and perturbed expression of immune-related edited transcripts. Cathepsin S (CTSS) was identified as a central regulatory node: elevated A-to-I editing within its 3' UTR in ICU patients stabilizes CTSS mRNA. Without stratifying by disease severity, ADAR expression and global editing showed no significant sex differences; the large sex divergence only appeared among ICU patients. This indicates severity-dependent, not infection-innate, disruption of A-to-I editing, disproportionately amplified in critically ill males. CTSS 3'UTR editing may serve as a biomarker for patient stratification, revealing a mechanistic connection between epitranscriptomic changes and male-biased severe COVID-19.
SN - 1547-6286
SN - 1555-8584
ER -